EGFR and cancer: In cancer cells, GOLM1 has the ability to be released into the cytoplasm and acts as a molecular chaperone to interact with various tumour‐related molecules such as EGFR, RTK, MMP2, MMP7 and B3‐H7, exerting a pro cancer effect.10, 32, 33, 34